A 2-year prospective study to evaluate the onset of action of Mavenclad in subjects with highly active relapsing multiple sclerosis.
- Skibina, Olga (Primary Chief Investigator (PCI))
- O'Brien, Terence (Chief Investigator (CI))
Project: Research
Project: Research